Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 354B (ZNF354B) is a protein-coding gene that encodes a transcriptional repressor belonging to the zinc finger family. It binds specifically to DNA, enabling regulation of gene expression through pathways associated with RNA polymerase II. Upon activation by RAS protein signaling, ZNF354B recruits other DNA-binding proteins and chromatin-modifying complexes to silence transcription at target loci, potentially playing a role in epigenetic gene regulation. ZNF354B is expressed mainly in the nucleus and is associated with diseases such as inflammatory bowel disease subtypes, but its role in other pathologies and as a therapeutic target remains under investigation[1][2][5][6].
Not applicable; there are no known drugs directly targeting ZNF354B
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 354B (ZNF354B).